Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan.

[1]  L. S. Fridericia.  Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken , 2009 .

[2]  Y. Hsueh,et al.  A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. , 2007, Toxicology and applied pharmacology.

[3]  R. Kwok,et al.  Chronic Arsenic Exposure and Cardiac Repolarization Abnormalities with QT Interval Prolongation in a Population-based Study , 2007, Environmental health perspectives.

[4]  E. Vicaut,et al.  Mannheim Carotid Intima-Media Thickness Consensus (2004–2006) , 2006, Cerebrovascular Diseases.

[5]  M. Sanguinetti,et al.  hERG potassium channels and cardiac arrhythmia , 2006, Nature.

[6]  A. Moss,et al.  QT Interval: How to Measure It and What Is “Normal” , 2006, Journal of cardiovascular electrophysiology.

[7]  A. Sharrett,et al.  Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. , 2005, American journal of epidemiology.

[8]  B. Paulweber,et al.  Relationship of QT interval duration with carotid intima media thickness in a clinically healthy population undergoing cardiovascular risk screening , 2005, Journal of internal medicine.

[9]  C. Obejero-Paz,et al.  Mechanisms of arsenic-induced prolongation of cardiac repolarization. , 2004, Molecular pharmacology.

[10]  C. Chiang,et al.  Effects of Arsenic Trioxide on Electrocardiography , 2004 .

[11]  A. Folsom,et al.  Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. , 2004, Journal of the American College of Cardiology.

[12]  D. Roden,et al.  Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium Currents , 2003, Circulation.

[13]  A. Folsom,et al.  Prognostic Significance of Corrected QT and Corrected JT Interval for Incident Coronary Heart Disease in a General Population Sample Stratified by Presence or Absence of Wide QRS Complex: The ARIC Study With 13 Years of Follow-Up , 2003, Circulation.

[14]  D. Nordstrom.  Worldwide Occurrences of Arsenic in Ground Water , 2002, Science.

[15]  J. Jeng,et al.  Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis , 2002, Circulation.

[16]  G. Bruno,et al.  Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population‐based cohort , 2002, Journal of internal medicine.

[17]  T. Ley,et al.  Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. , 2001, Blood.

[18]  M. Sanguinetti,et al.  Molecular and Cellular Mechanisms of Cardiac Arrhythmias , 2001, Cell.

[19]  R. Ohno,et al.  Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia , 2000, Annals of Internal Medicine.

[20]  B. Howard,et al.  Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. , 2000, Circulation.

[21]  J D Dawson,et al.  Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. , 1999, Circulation.

[22]  M. Rewers,et al.  Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). , 1999, Stroke.

[23]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[24]  C. Chen,et al.  Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. , 1997, Stroke.

[25]  H. Bazett,et al.  AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS. , 1997 .

[26]  C. Chen,et al.  Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[27]  D. Grobbee,et al.  Carotid artery intima‐media thickness as an indicator of generalized atherosclerosis , 1994, Journal of internal medicine.

[28]  G. Kay,et al.  Torsade de Pointes and T‐U Wave Alternans Associated with Arsenic Poisoning , 1990, Pacing and clinical electrophysiology : PACE.

[29]  A. From,et al.  Arsenic-induced atypical ventricular tachycardia. , 1980, The New England journal of medicine.

[30]  C. E. Kossmann.  The Normal Electrocardiogram , 1953, Circulation.

[31]  R. Calderon,et al.  Arsenic : exposure and health effects , 1997 .

[32]  M. Lai,et al.  Increased prevalence of hypertension and long-term arsenic exposure. , 1995, Hypertension.

[33]  T. Chou.  Electrocardiography In Clinical Practice , 1979 .